Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Gandhi

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Annals of Internal Medicine|November 16, 2020
In type 2 diabetes, some glucose-lowering drugs reduce HbA<sub>1c</sub> more than others; drugs do not differ for mortalityGunjan Y Gandhi
Annals of Internal Medicine|November 1, 2021
In type 2 diabetes, tirzepatide reduced HbA<sub>1c</sub> vs. semaglutideGunjan Y Gandhi
Annals of Internal Medicine|April 3, 2023
In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiencyGunjan Y Gandhi
Annals of Internal Medicine|October 2, 2023
In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily glargine at 52 wkHeiba Belal, Gunjan Y Gandhi
Annals of Internal Medicine|October 6, 2025
In early T2D inadequately controlled with diet and exercise, once-daily orforglipron reduced HbA<sub>1c</sub> vs. placebo at 40 wkMaham Shahid, Gunjan Y Gandhi,
Annals of Internal Medicine|October 2, 2023
In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily degludec at 26 wkHeiba Belal, Gunjan Y Gandhi
Annals of Internal Medicine|June 30, 2025
In patients with diabetes and previous MI, high-dose multivitamins and minerals did not reduce CV eventsMaham Shahid, Gunjan Y Gandhi,
Annals of Internal Medicine|July 31, 2023
In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA<sub>1c</sub> at 26 wkHeiba Belal, Gunjan Y Gandhi
Drugs & Aging|October 19, 2021
Clinical Considerations for Insulin Therapy in Older Adults with Type 1 DiabetesGunjan Y Gandhi, Arshag D Mooradian
Journal of Diabetes Science and Technology|February 11, 2010
Glycemic control in the medical intensive care unitMichelle A Kovalaske, Gunjan Y Gandhi
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Annals of Internal Medicine|November 16, 2020
In type 2 diabetes, some glucose-lowering drugs reduce HbA<sub>1c</sub> more than others; drugs do not differ for mortalityGunjan Y Gandhi
Annals of Internal Medicine|November 1, 2021
In type 2 diabetes, tirzepatide reduced HbA<sub>1c</sub> vs. semaglutideGunjan Y Gandhi
Annals of Internal Medicine|April 3, 2023
In pituitary adenoma surgery, no vs. perioperative hydrocortisone was noninferior for new-onset adrenal insufficiencyGunjan Y Gandhi
Annals of Internal Medicine|October 2, 2023
In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily glargine at 52 wkHeiba Belal, Gunjan Y Gandhi
Annals of Internal Medicine|October 6, 2025
In early T2D inadequately controlled with diet and exercise, once-daily orforglipron reduced HbA<sub>1c</sub> vs. placebo at 40 wkMaham Shahid, Gunjan Y Gandhi,
Annals of Internal Medicine|October 2, 2023
In T2DM uncontrolled with noninsulin glucose-lowering agents, weekly icodec reduced HbA<sub>1c</sub> vs. daily degludec at 26 wkHeiba Belal, Gunjan Y Gandhi
Annals of Internal Medicine|June 30, 2025
In patients with diabetes and previous MI, high-dose multivitamins and minerals did not reduce CV eventsMaham Shahid, Gunjan Y Gandhi,
Annals of Internal Medicine|July 31, 2023
In uncontrolled T2DM treated with a basal-bolus insulin regimen, weekly icodec was noninferior to daily glargine for HbA<sub>1c</sub> at 26 wkHeiba Belal, Gunjan Y Gandhi
Drugs & Aging|October 19, 2021
Clinical Considerations for Insulin Therapy in Older Adults with Type 1 DiabetesGunjan Y Gandhi, Arshag D Mooradian
Journal of Diabetes Science and Technology|February 11, 2010
Glycemic control in the medical intensive care unitMichelle A Kovalaske, Gunjan Y Gandhi
Pageof 5